Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells

Cancer Letters

Volumn 309, Issue 2, 2011, Pages 236-242

  Okabe, Kyoko ^a   Kato, Kohei ^a   Teranishi, Miki ^a   Okumura, Mai ^a   Fukui, Rie ^a   Mori, Toshio ^b   Fukushima, Nobuyuki ^a   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell migration; Liver; Lpar3; Rat; TPA

Indexed keywords

INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDIC ACID RECEPTOR 3; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; HEPATOMA CELL; LIVER CANCER; LIVER CELL; LPAR1 GENE; LPAR2 GENE; LPAR3 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL CELLS; HEPATOCYTES; LIVER; LIVER NEOPLASMS; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE;

RATTUS;

EID: 79960843609     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.020     Document Type: Article

References (34)

1. Lin M.-E., Herr D.R., Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostag. Other Lipid Mediat. 2010, 91:130-138.
2. Aoki J., Inoue A., Okudaira S. Two pathway for lysophosphatidic acid production. Biochim. Biophys. Acta 2008, 1781:513-518.
3. Ishii I., Fukushima N., Ye X., Chun J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 2004, 73:321-354.
4. Contos J.J.A., Ishii I., Chun J. Lysophosphatidic acid receptors. Mol. Pharmacol. 2000, 58:1188-1196.
5. Fang X., Gaudette D., Furui T. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann. NY Acad. Sci. 2000, 905:188-208.
6. Fang X., Schummer M., Mao M., Yu S., Tabassam F.H., Swaby R., Hasegawa Y., Tanyi J.L., LaPushin R., Eder A., Jaffe R., Erickson J., Mills G.B. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta 2002, 1582:257-264.
7. Watanabe N., Ikeda H., Nakamura K., Ohkawa R., Kume Y., Aoki J., Hama K., Okudaira S., Tanaka M., Tomiya T., Yanase M., Tejima K., Nishikawa T., Arai M., Arai H., Omata M., Fujiwara K., Yatomi Y. Both plasma lysophosphatidic acid and serum autotoxin levels are increased in chronic hepatitis C. J. Clin. Gastroenterol. 2007, 41:616-623.
8. Ikeda H., Yatomi Y., Yanase M., Satoh H., Nishihara A., Kawabata M., Fujiwara K. Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. Biochem. Biophys. Res. Commun. 1998, 248:436-440.
9. Wu J., Zern M.A. Hepatic stellate cells: a target for the treatment of liver fibrosis. J. Gastroenterol. 2000, 35:665-672.
10. Furui T., LaPushin R., Mao M., Khan H., Watt S.R., Watt M.A.V. Overexpression of Edg-2/vzg-1 Induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin. Cancer Res. 1999, 5:4308-4318.
11. Goetzl E.J., Dolezalova H., Kong Y., Hu Y.L., Jaffe R.B., Kalli K.R., Conover C.A. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 1999, 59:5370-5375.
12. Shida D., Watanabe T., Aoki J., Hama K., Kitayama J., Sonoda H., Kishi Y., Yamaguchi H., Sasaki S., Sako A., Konishi T., Arai H., Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Invest. 2004, 84:1352-1362.
13. Shida D., Kitayama J., Yanaguchi H., Okaji Y., Tsuno N.H., Watanabe T., Takuwa Y., Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003, 63:1706-1711.
14. Schulte K.M., Beyer A., Kohrer K., Oberhauser S., Roher H.D. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int. J. Cancer 2001, 92:249-256.
15. Tsujino M., Fujii M., Okabe K., Mori T., Fukushima N., Tsujiuchi T. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch. 2010, 457:669-676.
16. Okabe K., Hayashi M., Wakabayashi N., Yamawaki Y., Teranishi M., Fukushima N., Tsujiuchi T. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology 2010, 77:309-314.
17. Yu S., Murph M.M., Lu Y., Liu S., Hall H.S., Liu J., Stephens C., Fang X., Mills G.B. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J. Natl. Cancer Inst. 2008, 100:1630-1642.
18. Hayashi M., Okabe K., Yamawaki Y., Teranishi M., Honoki K., Mori T., Fukushima N., Tsujiuchi T. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem. Biophys. Res. Commun. 2011, 405:450-454.
19. Yotti L.P., Chang C.C., Trosko J.E. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 1979, 208:1089-1091.
20. Enomoto T., Sasaki Y., Shiba Y., Kanno Y., Yamasaki H. Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture. Proc. Natl. Acad. Sci. USA 1981, 78:5628-5632.
21. Lin C.W., Shen S.C., Chien C., Yang L.Y., Shia L.T., Chen Y.C. 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCα/ERK/NF-κB-dependent MMP-9 expression. J. Cell Physiol. 2010, 225:472-481.
22. Nabeshima K., Komada N., Kishi J., Koita H., Inoue T., Hayakawa T., Koono M. TPA-enhanced invasion of matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. Int. J. Cancer 1993, 55:974-981.
23. Ren P., Mehta P.P., Ruch R.J. Inhibition of gap junctional intercellular communication by tumor promoters in connexin43 and connexin32-expressing liver cells: cell specificity and role of protein kinase C. Carcinogenesis 1998, 19:169-175.
24. Nabeshima K., Inoue T., Shimao Y., Kataoka H., Koono M. TPA-induced cohort migration of well-differentiated human rectal adenocarcinoma cells: cells move in a RGD-dependent manner on fibronection produced by cells, and phosphorylation of E-cadherin/catenin complex is induced independently of cell-extracellular matrix interactions. Virchows Arch. 1998, 433:243-253.
25. K. Okabe, M. Hayashi, Y. Yamawaki, M. Teranishi, K. Honoki, T. Mori, N. Fukushima, T. Tsujiuchi, Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells, Mol. Carcinogen. doi:10.1002/mc.20750.
26. Shano S., Hatanaka K., Ninose S., Moriyama R., Tsujiuchi T., Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim. Biophys. Acta 2008, 1783:748-759.
27. Oh S.Y., Grupen C.G., Murray A.W. Phorbol ester induces phosphorylation and down-regulation of connexin 43 in WB cells. Biochem. Biophys. Acta 1991, 1094:243-245.
28. Hii C.S.T., Oh S.-Y., Schmidt S.A., Clark K.J., Murray A.W. Lysophosphatidic acid inhibits gap-junctional communication and stimulates phosphorylation of connexin-43 in WB cells: possible involvement of the mitogen-activated protein kinase cascade. Biochem. J. 1994, 303:475-479.
29. Ko C.H., Shen S.C., Lee T.J., Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol. Cancer Ther. 2005, 4:281-290.
30. Lin C.W., Hou W.C., Shen S.C., Juan S.H., Ko C.H., Wang L.M., Chen Y.C. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008, 29:1807-1815.
31. Shen Z., Belonson J., Morton R.E., Xu Y., Xu Y. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol. Oncol. 1998, 71:364-368.
32. An S., Bleu T., Halmark O.G., Goetzl E.J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 1998, 273:7906-7910.
33. Bandoh K., Aoki J., Hosono H., Kobayashi S., Murakami-Murofushi K., Tsujimoto M., Arai H., Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 1999, 274:27776-27785.
34. Zaslavsky A., singh L.S., Tan H., Ding H., Liang Z., Xu Y. Homo- and hetero-demerization of LPA/SIP receptors, OGR1 and GPR4. Biochim. Biophys. Acta 2006, 1761:1200-1212.